(Cairo and London) - In relation to the share purchase agreement (the "SPA") signed on 20 December 2021 by IDH (or "the Company") for the acquisition of a 50% stake in Islamabad Diagnostic Center ("IDC"), IDH has notified Evercare IGA Holdings Limited (the "Seller") of its decision to terminate the SPA on 29 August 2022.
Tap or click here to read the full announcement in pdf.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
IDH - Integrated Diagnostics Holdings plc published this content on 06 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 September 2022 14:49:01 UTC.